Company intelligence / Profile preview

AMVIO

Gorakhpur, Uttar Pradesh, Indiauk.linkedin.com ↗
Ownership
Private
Development stage
Other
01

Overview

Amvia Biotech is an established Indian pharmaceutical company with a portfolio exceeding 100 formulations, primarily focused on generic medicines and vitamins for common indications such as pain relief, fever reduction, gastrointestinal issues, iron deficiency anemia, respiratory conditions, and vitamin deficiencies. The company emphasizes quality and affordability in its offerings.

Therapeutic areas
NeurologyMetabolic DisordersPulmonologyInfectious DiseasesHematologyGastroenterology
Modalities
Small moleculeVitamin
Industry
Biotech

Beyond the preview

Go deeper on AMVIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMVIO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call